UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 73

Sortiert nach

Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling

Nature neuroscience, 2009-09, Vol.12 (9), p.1152-1158

2009

Link zum Volltext

Verfügbarkeit prüfen

Targeting the endocannabinoid system in the treatment of fragile X syndrome

Nature medicine, 2013-05, Vol.19 (5), p.603-607

2013

Link zum Volltext

Verfügbarkeit prüfen

Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain

Journal of neurochemistry, 2007-08, Vol.102 (4), p.1105-1114

2007

Link zum Volltext

Verfügbarkeit prüfen

Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids

Philosophical transactions of the Royal Society of London. Series B. Biological sciences, 2012-12, Vol.367 (1607), p.3254

2012

Link zum Volltext

Verfügbarkeit prüfen

Differential Role of Anandamide and 2-Arachidonoylglycerol in Memory and Anxiety-like Responses

Biological psychiatry (1969), 2011-09, Vol.70 (5), p.479-486

2011

Link zum Volltext

Verfügbarkeit prüfen

Microglial activation underlies cerebellar deficits produced by repeated cannabis exposure

The Journal of clinical investigation, 2013-07, Vol.123 (7), p.2816-2831

2013

Link zum Volltext

Verfügbarkeit prüfen

Dissociation of the Pharmacological Effects of THC by mTOR Blockade

Neuropsychopharmacology (New York, N.Y.), 2013-06, Vol.38 (7), p.1334-1343

2013

Link zum Volltext

Verfügbarkeit prüfen

The cannabis paradox: when age matters

Nature medicine, 2017-06, Vol.23 (6), p.661-662

2017

Link zum Volltext

Verfügbarkeit prüfen

Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of memory consolidation

Proceedings of the National Academy of Sciences - PNAS, 2016-08, Vol.113 (35), p.9904-9909

2016

Link zum Volltext

Verfügbarkeit prüfen

Auricular transcutaneous vagus nerve stimulation improves memory persistence in naïve mice and in an intellectual disability mouse model

Brain stimulation, 2020-03, Vol.13 (2), p.494-498

2020

Link zum Volltext

Verfügbarkeit prüfen

Monoacylglycerol lipase blockade impairs fine motor coordination and triggers cerebellar neuroinflammation through cyclooxygenase-2

Brain, behavior, and immunity, 2019-10, Vol.81, p.399-409

2019

Link zum Volltext

Verfügbarkeit prüfen

Cannabinoid type-1 receptor blockade restores neurological phenotypes in two models for Down syndrome

Neurobiology of disease, 2019-05, Vol.125, p.92-106

2019

Link zum Volltext

Verfügbarkeit prüfen

Protein Kinase C-Gamma Knockout Mice Show Impaired Hippocampal Short-Term Memory While Preserved Long-Term Memory

Molecular neurobiology, 2021-02, Vol.58 (2), p.617-630

2021

Link zum Volltext

Verfügbarkeit prüfen

Hippocampal Protein Kinase C Signaling Mediates the Short-Term Memory Impairment Induced by Delta9-Tetrahydrocannabinol

Neuropsychopharmacology (New York, N.Y.), 2018-04, Vol.43 (5), p.1021-1031

2018

Link zum Volltext

Verfügbarkeit prüfen

Serotonergic mechanisms involved in antidepressant-like responses evoked by GLT-1 blockade in rat infralimbic cortex

Neuropharmacology, 2018-09, Vol.139, p.41-51

2018

Link zum Volltext

Verfügbarkeit prüfen

Sex-dependent psychoneuroendocrine effects of THC and MDMA in an animal model of adolescent drug consumption

PloS one, 2013-11, Vol.8 (11), p.e78386

2013

Link zum Volltext

Verfügbarkeit prüfen

New insights into the molecular pathophysiology of fragile X syndrome and therapeutic perspectives from the animal model

The international journal of biochemistry & cell biology, 2014-08, Vol.53, p.121-126

2014

Link zum Volltext

Verfügbarkeit prüfen

Auricular Transcutaneous Vagus Nerve Stimulation Acutely Modulates Brain Connectivity in Mice

Frontiers in cellular neuroscience, 2022-04, Vol.16, p.856855-856855

2022

Link zum Volltext

Verfügbarkeit prüfen

BDNF impairment in the hippocampus is related to enhanced despair behavior in CB₁ knockout mice

Journal of neurochemistry, 2008-04, Vol.105 (2), p.565-572

2008

Link zum Volltext

Verfügbarkeit prüfen

Amyloid β-Peptide Causes the Permanent Activation of CaMKIIα through Its Oxidation

International journal of molecular sciences, 2022-12, Vol.23 (23), p.15169

2022

Link zum Volltext

Verfügbarkeit prüfen

CB1 Cannabinoid Receptors Mediate Cognitive Deficits and Structural Plasticity Changes During Nicotine Withdrawal

Biological psychiatry (1969), 2017-04, Vol.81 (7), p.625-634

2017

Link zum Volltext

Verfügbarkeit prüfen

Advances in the field of cannabinoid-opioid cross-talk

Addiction biology, 2008-06, Vol.13 (2), p.213-224

2008

Link zum Volltext

Verfügbarkeit prüfen

Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model

Genes, 2016-08, Vol.7 (9), p.56-56

2016

Link zum Volltext

Verfügbarkeit prüfen

A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome

Clinical nutrition (Edinburgh, Scotland), 2020-02, Vol.39 (2), p.378-387

2020

Link zum Volltext

Verfügbarkeit prüfen

Functional protection in J20/VLW mice: a model of non-demented with Alzheimer's disease neuropathology

Brain (London, England : 1878), 2022-04, Vol.145 (2), p.729-743

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(68)

Publikationsform

Artikel
(72)
Buchkapitel
(1)

Sprache

Englisch
(73)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

Science & Technology
(46)
Life Sciences & Biomedicine
(43)
Animals
(38)
Neurosciences
(26)
Neurosciences & Neurology
(26)
Male
(22)
Mice
(22)
Humans
(16)
Rats
(15)
Biological And Medical Sciences
(13)
Memory
(13)
Mice, Knockout
(11)
Biochemistry & Molecular Biology
(10)
Brain - Metabolism
(10)
Cannabinoides
(9)
Hippocampus
(9)
Rats, Sprague-Dawley
(9)
Female
(8)
Receptor, Cannabinoid, Cb1 - Metabolism
(8)
Brain - Drug Effects
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling

Targeting the endocannabinoid system in the treatment of fragile X syndrome

Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain

Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids

Differential Role of Anandamide and 2-Arachidonoylglycerol in Memory and Anxiety-like Responses

Microglial activation underlies cerebellar deficits produced by repeated cannabis exposure

Dissociation of the Pharmacological Effects of THC by mTOR Blockade

The cannabis paradox: when age matters

Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of memory consolidation

Auricular transcutaneous vagus nerve stimulation improves memory persistence in naïve mice and in an intellectual disability mouse model

Monoacylglycerol lipase blockade impairs fine motor coordination and triggers cerebellar neuroinflammation through cyclooxygenase-2

Cannabinoid type-1 receptor blockade restores neurological phenotypes in two models for Down syndrome

Protein Kinase C-Gamma Knockout Mice Show Impaired Hippocampal Short-Term Memory While Preserved Long-Term Memory

Hippocampal Protein Kinase C Signaling Mediates the Short-Term Memory Impairment Induced by Delta9-Tetrahydrocannabinol

Serotonergic mechanisms involved in antidepressant-like responses evoked by GLT-1 blockade in rat infralimbic cortex

Sex-dependent psychoneuroendocrine effects of THC and MDMA in an animal model of adolescent drug consumption

New insights into the molecular pathophysiology of fragile X syndrome and therapeutic perspectives from the animal model

Auricular Transcutaneous Vagus Nerve Stimulation Acutely Modulates Brain Connectivity in Mice

BDNF impairment in the hippocampus is related to enhanced despair behavior in CB₁ knockout mice

Amyloid β-Peptide Causes the Permanent Activation of CaMKIIα through Its Oxidation

CB1 Cannabinoid Receptors Mediate Cognitive Deficits and Structural Plasticity Changes During Nicotine Withdrawal

Advances in the field of cannabinoid-opioid cross-talk

Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model

A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome

Functional protection in J20/VLW mice: a model of non-demented with Alzheimer's disease neuropathology

Suchergebnisse filtern